Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic Brain Injury and Filing of International Patent Application

by NASDAQ Market News March 19, 2021

NASDAQ Market News
Click here to email author

Longeveron Inc. to Present at the Q1 Virtual Investor Summit on March 24

Tonix Pharmaceuticals Announces Issuance of U.S. Patent for Compositions and Uses of Tianeptine Oxalate Salt, the Active Ingredient of TNX-601 CR

Ads